ARTELO BIOSCIENCES, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Artelo Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2018 to Q3 2024.
  • Artelo Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 3.23M shares, a 9.46% increase year-over-year.
  • Artelo Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2019 was 2.17M shares, a 70.1% increase from 2018.
  • Artelo Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2018 was 1.28M shares, a 33.7% decline from 2017.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 3.23M +279K +9.46% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q3 2023 2.95M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q1 2020 3.43M +1.51M +78.6% Dec 1, 2019 Feb 29, 2020 10-Q 2020-04-13
Q4 2019 3.38M +1.62M +92.6% Sep 1, 2019 Nov 30, 2019 10-Q 2020-01-14
Q3 2019 2.17M Jun 1, 2019 Aug 31, 2019 10-K/A 2019-12-18
Q2 2019 2.27M +675K +42.4% Mar 1, 2019 May 31, 2019 10-Q 2019-07-15
Q1 2019 1.92M Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-13
Q4 2018 1.75M Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-14
Q2 2018 1.59M Mar 1, 2018 May 31, 2018 10-Q 2019-07-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.